3 weeks ago
Dhoot Transmission, Molbio Diagnostics IPOs See Over 70 Times Subscription
When a company wants money to grow, it can sell small pieces of itself, called shares, to the public for the first time — this is called an IPO.
Two Indian companies, Dhoot Transmission and Molbio Diagnostics, are doing exactly this.
Investors were very excited and asked for more than 70 times the shares that were available in each IPO.
Dhoot Transmission is a company based in Maharashtra that makes wiring harnesses, which are bundles of wires.
Molbio Diagnostics is a company based in Goa that makes quick medical tests for use right where patients are cared for, called point-of-care diagnostics.
The companies plan to use the money to pay back loans and build new factories and research facilities.
Some of the world's biggest investors, like BlackRock and Temasek, have already given the companies money.
Once an IPO ends, people can buy and sell the shares on a stock exchange.
On August 17, shares of both companies will begin trading on India's two main stock exchanges, the BSE and the NSE.
The Dhoot Transmission IPO was subscribed 74.21 times, and Molbio Diagnostics' IPO 70.26 times, on the final day of bidding.
Dhoot Transmission's ₹3,067-crore issue, priced at ₹829-871 per share, includes a fresh issue of up to ₹1,400 crore and an offer-for-sale of up to 1.91 crore shares by promoters, including an entity of private equity firm Bain Capital.
Dhoot Transmission raised ₹918.3 crore from anchor investors including BlackRock, the Abu Dhabi Investment Authority and SBI Mutual Funds.
Molbio Diagnostics, backed by Temasek and Motilal Oswal Private Equity, raised ₹281.5 crore from anchor investors, with a price band of ₹768-807 per share.
Both stocks are proposed to be listed on the BSE and NSE on August 17, 2026.
- Who
- Dhoot Transmission, a Maharashtra-based wiring harness maker, and Molbio Diagnostics, a Goa-based point-of-care diagnostics company, with anchor investors including BlackRock, the Abu Dhabi Investment Authority, SBI Mutual Funds, Temasek and Motilal Oswal Private Equity.
- What
- Both mainboard IPOs were heavily oversubscribed — 74.21 times for Dhoot Transmission and 70.26 times for Molbio Diagnostics — on the closing day of bidding.
- Where
- India; Dhoot Transmission is based in Maharashtra and Molbio Diagnostics in Goa, with both stocks proposed to be listed on the BSE and NSE.
- When
- On the final day of bidding, with the report published on August 12, 2026; listing is proposed for August 17, 2026.
- Why
- To raise fresh capital — Dhoot Transmission for repayment of borrowings, investment in subsidiaries and new wiring harness manufacturing plants, and Molbio Diagnostics for R&D infrastructure, plant and machinery, and general corporate purposes.
Key facts
- Dhoot Transmission IPO subscription
- 74.21 times
- Molbio Diagnostics IPO subscription
- 70.26 times
- Dhoot Transmission IPO size
- ₹3,067 crore
- Dhoot Transmission price band
- ₹829-871 per share
- Molbio Diagnostics price band
- ₹768-807 per share
- Dhoot Transmission anchor investment
- ₹918.3 crore
- Molbio Diagnostics anchor investment
- ₹281.5 crore
- Proposed listing
- August 17, 2026, on BSE and NSE









